Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high‐risk proliferative diabetic retinopathy (IBeHi study)

. Purpose: To evaluate the effects of panretinal photocoagulation (PRP) compared with PRP plus intravitreal bevacizumab on best corrected visual acuity (BCVA) and total area of fluorescein leakage from active new vessels (NVs) in patients with high‐risk proliferative diabetic retinopathy (PDR). Met...

Full description

Saved in:

Bibliographic Details
Published in:	Acta ophthalmologica (Oxford, England) Vol. 86; no. 4; pp. 385 - 389
Main Authors:	Tonello, Matheus, Costa, Rogério A., Almeida, Felipe P. P., Barbosa, José C., Scott, Ingrid U., Jorge, Rodrigo
Format:	Journal Article
Language:	English
Published:	Oxford, UK Blackwell Publishing Ltd 01-06-2008
Subjects:	Adult Aged angiogenesis Angiogenesis Inhibitors - administration & dosage Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal, Humanized Bevacizumab Cell Division - drug effects Combined Modality Therapy diabetes Diabetic Retinopathy - drug therapy Diabetic Retinopathy - surgery Female Follow-Up Studies Humans Injections laser Laser Coagulation - methods Male Middle Aged Prospective Studies Risk Factors treatment Treatment Outcome vascular endothelial growth factor Visual Acuity Vitreous Body
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!